Dr. Anil Sood is a respected Houston cancer researcher who has served on the University of Texas MD Anderson Cancer Center faculty for 16 years and is director of the Blanton-Davis Ovarian Cancer Research Program. Among Dr. Anil Sood’s areas of extensive research is mechanisms of cancer metastasis.
Metastatic breast cancer involves cancerous cells breaking free from the initial breast tumor and migrating via blood vessels or the lymphatic system. The latter system comprises vessels and nodes, fulfilling the vital function of removing viruses and bacteria as well as waste produced by cells.
Unfortunately, the lymphatic system can be a conduit for cancerous cells to remain within the body for years after the disease is initially diagnosed and treated. Approximately one third of women who are treated for early-stage breast cancer will go on to develop the metastatic form of the disease. Regions to which breast cancer often spreads include the brain, lung, and liver, with each location presenting distinct symptoms. It can also spread to bones.
Foundation for Women’s Cancer
A professor in the Department of Gynecologic Oncology and Reproductive Medicine at the MD Anderson Cancer Center at the University of Texas, Anil Sood also serves as co-director of the institution’s Center for RNA Interference and Non-Coding RNA and director of the Blanton-Davis Ovarian Cancer Research Program. In addition, Anil Sood supports the work of organizations such as the Foundation for Women’s Cancer.
Founded to raise awareness of and fund research on gynecologic cancers, the Foundation for Women’s Cancer also considers education to be an important part of its mission. To that end, it offers courses for patients and the public. Upcoming free courses include the following.
1. Ovarian Cancer Education Course in New York City on Saturday, September 29, 2018, in the Stern Auditorium at Mt. Sinai Hospital: Taught by a team of researchers, physicians, and others, this day-long course will feature up-to-date information on ovarian cancer clinical trials and research. It will also include continental breakfast and lunch.
2. Gynecologic Cancer Course in Washington, DC, on Saturday, November 3, 2018, at the JW Marriott. This day-long course will focus on gynecologic cancer-related trials and research. Cancer care team members, including physicians and researchers, will present the information. The event will include continental breakfast as well as lunch.